tiprankstipranks

Sheldon L. Koenig Insider Profile

4 Followers
Sheldon L. Koenig, EVP & CCO at Portola Pharma, holds 752.27K shares in Esperion (Ticker: ESPR), holds 0.00 shares in Portola Pharma (Ticker: PTLA). Most recently, Sheldon L. Koenig Sold ― shares of Esperion on Sep 18, 2024 for an estimated value of 26.04K.
tipranks
Sheldon L. Koenig

Sheldon L. Koenig
Portola Pharma (PTLA)
EVP & CCO

Ranked #74,471 out of 99,335 Corporate Insiders

Profitable Transactions

33%
2 out of 6 Profitable Transactions

Average Return

-14.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Sheldon L. Koenig's holdings

Insider Roles

Esperion
(ESPR)
President & CEO, Director
Roles that Sheldon L. Koenig holds in companies

Most Profitable Insider Trade

Stock:
Esperion
(ESPR)
Rating:Informative Buy
Date:May 10, 2023 - May 10, 2024
Return:+50.00%
The most profitable trade made by Sheldon L. Koenig

Sheldon L. Koenig's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PTLA
Portola Pharma
Jul 02, 2020
Uninformative Buy
4.08K
$0.00
Esperion
Sep 18, 2024
President & CEO, Director
Informative Sell
26.04K
$1.86M
List of latest transactions for each holding click on a transaction to see Sheldon L. Koenig's performance on stock

Sheldon L. Koenig insider profile FAQ

What is the percentage of profitable transactions made by Sheldon L. Koenig?
The percentage of profitable transactions made by Sheldon L. Koenig is 33%.
    What is the average return per transaction made by Sheldon L. Koenig?
    The average return per transaction made by Sheldon L. Koenig is -14.80%.
      What stocks does Sheldon L. Koenig hold?
      Sheldon L. Koenig holds: PTLA, ESPR stocks.
        What was Sheldon L. Koenig’s latest transaction?
        Sheldon L. Koenig latest transaction was an Informative Sell of $26.04K.
          What was Sheldon L. Koenig's most profitable transaction?
          Sheldon L. Koenig’s most profitable transaction was an Informative Buy of ESPR stock on May 10, 2023. The return on the trade was 50.00%.
            What is Sheldon L. Koenig's role in Portola Pharma?
            Sheldon L. Koenig's role in Portola Pharma is EVP & CCO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.